Amyloid-associated proteins α1-antichymotrypsin and apolipoprotein E promote assembly of Alzheimer β-protein into filaments

Ma, Jianyi, Yee, Ann, Brewer, H. Bryan, Das, Saumya, Potter, Huntington·1994·Nature
DOI 10.1038/372092a0

Cited by (869)

Items 301–400 of 869

  1. Distribution of Aβ-associated proteins in cerebrovascular amyloid of Alzheimer's disease
    Marcel M. Verbeek, Irene Otte‐Höller, Robert Veerhuis, Dirk J. Ruiter, Robert M.W. de Waal · 1998 · Acta Neuropathologica
  2. Amyloid β40/42 clearance across the blood-brain barrier following intra-ventricular injections in wild-type, apoE knock-out and human apoE3 or E4 expressing transgenic mice
    Yong Ji, Bruno Permanne, Einar M. Sigurdsson, David M. Holtzman, Thomas Wısnıewskı · 2001 · Journal of Alzheimer s Disease
  3. Development of Beta-Amyloid-induced Neurodegeneration in Alzheimer's Disease and Novel Neuroprotective Strategies
    Christian Hölscher · 2005 · Reviews in the Neurosciences
  4. Inhibition of Alzheimer β-Peptide Fibril Formation by Serum Amyloid P Component
    Sabina M Janciauskiene, Pablo Garcı́a de Frutos, Erik Carlemalm, Björn Dahlbäck, Sten Eriksson · 1995 · Journal of Biological Chemistry
  5. ApoE and Aβ1–42 Interactions: Effects of Isoform and Conformation on Structure and Function
    Manelli, Arlene M., Stine, W. Blaine, Van Eldik, Linda J., LaDu, Mary Jo · 2004 · Journal of Molecular Neuroscience
  6. Molecular mechanisms that underlie structural and functional changes atthe postsynaptic membrane duringsynaptic plasticity
    Wheal, Howard V, Chen, Ying, Mitchell, John, Schachner, Melitta, Maerz, Winfried, Wieland, Heinrich, van Rossum, Denise, Kirsch, Joachim · 1998 · Progress in Neurobiology
  7. Amyloid-Forming Properties of Human Apolipoproteins: Sequence Analyses and Structural Insights
    Madhurima Das, Olga Gursky · 2015 · Advances in experimental medicine and biology
  8. In-depth Site-specific Analysis of N-glycoproteome in Human Cerebrospinal Fluid and Glycosylation Landscape Changes in Alzheimer's Disease
    Zhengwei Chen, Qinying Yu, Qing Yu, Jillian Johnson, Richard David Shipman, Xiaofang Zhong, Junfeng Huang, Sanjay Asthana, Cynthia M. Carlsson, Ozioma C. Okonkwo et al. · 2021 · Molecular & Cellular Proteomics
  9. Apolipoprotein E: Essential Catalyst of the Alzheimer Amyloid Cascade
    Huntington Potter, Thomas Wısnıewskı · 2012 · International Journal of Alzheimer s Disease
  10. Accelerated Aβ aggregation in the presence of GM1‐ganglioside‐accumulated synaptosomes of aged apoE4‐knock‐in mouse brain
    Naoki Yamamoto, Urule Igbabvoa, Y. Shimada, Y. Ohno-Iwashita, Mariko Kobayashi, W. Wood, S. Fujita, K. Yanagisawa · 2004 · FEBS Letters
  11. Alzheimer Aβ Peptide Induces Chromosome Mis-Segregation and Aneuploidy, Including Trisomy 21: Requirement for Tau and APP
    Antoneta Granic, Jaya Padmanabhan, Michelle Norden, Huntington Potter · 2009 · Molecular Biology of the Cell
  12. Clusterin levels are increased in A lzheimer's disease and influence the regional distribution of Aβ
    James Scott Miners, Polly Clarke, Seth Love · 2016 · Brain Pathology
  13. Investigation of association of 13 polymorphisms in eight genes in southeastern African American Alzheimer disease patients as compared to age‐matched controls
    Rodney T. Perry, Julianne S. Collins, Lindy E. Harrell, Ronald T. Acton, Rodney C.P. Go · 2001 · American Journal of Medical Genetics
  14. Alzheimer Aβ neurotoxicity: Promotion by antichymotrypsin, ApoE4; inhibition by Aβ-related peptides
    Ma, Jianyi, Brewer, H.Bryan, Potter, Huntington · 1996 · Neurobiology of Aging
  15. Susceptibility of transgenic mice expressing human apolipoprotein E to closed head injury: The allele E3 is neuroprotective whereas E4 increases fatalities
    Sabo, T, Lomnitski, L, Nyska, A, Beni, S, Maronpot, R.R, Shohami, E, Roses, A.D, Michaelson, D.M · 2000 · Neuroscience
  16. Apolipoprotein E enhances uptake of soluble but not aggregated amyloid‐β protein into synaptic terminals
    Karen H. Gylys, Jeffrey A. Fein, Aiko M. Tan, Gregory M. Cole · 2003 · Journal of Neurochemistry
  17. Apolipoprotein E4 Domain Interaction Occurs in Living Neuronal Cells as Determined by Fluorescence Resonance Energy Transfer
    Qin Xu, Walter J. Brecht, Karl Heinrich Weisgraber, Robert W. Mahley, Yadong Huang · 2004 · Journal of Biological Chemistry
  18. Gelsolin inhibits the fibrillization of amyloid beta-protein, and also defibrillizes its preformed fibrils
    Indrani Ray, Abha Chauhan, Jerzy Węgiel, Ved P. S. Chauhan · 2000 · Brain Research
  19. Deposition of apolipoproteins E and J in senile plaques is topographically determined in both Alzheimer's disease and Down's syndrome brain
    Kida, Elizabeth, Choi-Miura, Nam-Ho, Wisniewski, Krystyna E. · 1995 · Brain Research
  20. Differential regulation of microglial activation by propentofylline via cAMP signaling
    Qiusheng Si, Yoichi Nakamura, Tadanori Ogata, Kiyoshi Kataoka, Peter Schubert · 1998 · Brain Research
  21. MicroRNA-195 rescues ApoE4-induced cognitive deficits and lysosomal defects in Alzheimer’s disease pathogenesis
    Jiqing Cao, Min Huang, Lei Guo, Li Zhu, Jianwei Hou, Larry Zhang, Adriana Pero, Sabrina Ng, Farida El Gaamouch, Gregory A. Elder et al. · 2020 · Molecular Psychiatry
  22. Alzheimer's and prion disease as disorders of protein conformation: implications for the design of novel therapeutic approaches
    Claudio A. Soto · 1999 · Journal of Molecular Medicine
  23. Exosome Production Is Key to Neuronal Endosomal Pathway Integrity in Neurodegenerative Diseases
    P. Mathews, E. Levy · 2019 · Frontiers in Neuroscience
  24. Effect of aldehydes derived from oxidative deamination and oxidative stress on β-amyloid aggregation; pathological implications to Alzheimer’s disease
    K. Chen, Michael Kazachkov, P. H. Yu · 2007 · Journal of Neural Transmission
  25. B Cell Granule Peptides Affect Human Islet Amyloid Polypeptide (IAPP) Fibril Formationin Vitro
    Sabina M Janciauskiene, Sten Eriksson, Eric Carlemalm, Bo Åhrén · 1997 · Biochemical and Biophysical Research Communications
  26. Molecular mechanisms initiating amyloid beta-fibril formation in Alzheimer's disease.
    Marina D. Kirkitadze, Anna Kowalska · 2005 · Acta Biochimica Polonica
  27. Glia-related pathomechanisms in Alzheimer's disease: a therapeutic target?
    Peter Schubert, Tadanori Ogata, Cristina Marchini, Stefano Ferroni · 2001 · Mechanisms of Ageing and Development
  28. Genetic risk factors in Alzheimer's disease.
    Louise A. Tilley, Kevin Morgan, Noor A Kalsheker · 1998 · Molecular Pathology
  29. Retinoic Acid Isomers Facilitate Apolipoprotein E Production and Lipidation in Astrocytes through the Retinoid X Receptor/Retinoic Acid Receptor Pathway
    Jing Zhao, Yuan Fu, Chia‐Chen Liu, Mitsuru Shinohara, Henrietta M. Nielsen, Qiang Dong, Takahisa Kanekiyo, Guojun Bu · 2014 · Journal of Biological Chemistry
  30. Apolipoprotein E lipoprotein particles inhibit amyloid-β uptake through cell surface heparan sulphate proteoglycan
    Yuan Fu, Jing Zhao, Yuka Atagi, Henrietta M. Nielsen, Chia‐Chen Liu, Honghua Zheng, Mitsuru Shinohara, Takahisa Kanekiyo, Guojun Bu · 2016 · Molecular Neurodegeneration
  31. Patterns and severity of vascular amyloid in Alzheimer’s disease associated with duplications and missense mutations in APP gene, Down syndrome and sporadic Alzheimer’s disease
    Mann, David M. A., Davidson, Yvonne S., Robinson, Andrew C., Allen, Nancy, Hashimoto, Tadafumi, Richardson, Anna, Jones, Matthew, Snowden, Julie S., Pendleton, Neil, Potier, Marie-Claude et al. · 2018 · Acta Neuropathologica
  32. Interactions Causing the Kinetic Trap in Serpin Protein Folding
    Hana Im, Mi-Sook Woo, Kwang Yeon Hwang, Myeong‐Hee Yu · 2002 · Journal of Biological Chemistry
  33. Distribution of beta amyloid associated proteins in plaques in Alzheimer's disease and in the non-demented elderly
    Shanshan Zhan, Robert Veerhuis, Wouter Kamphorst, Piet Eikelenboom · 1995 · Neurodegeneration
  34. Genetics of Alzheimer’s Disease in Caribbean Hispanic and African American Populations
    Christiane Reitz, Richard P Mayeux · 2013 · Biological Psychiatry
  35. Inhibition of Amyloidosis Using Low-Molecular-Weight Heparins
    Hong Zhu, Jin Yu, Mark S. Kindy · 2001 · Molecular Medicine
  36. Effect of (−)-epigallocatechin-3-gallate on human insulin fibrillation/aggregation kinetics
    Shihui Wang, Xiaoyan Dong, Yan Ping Sun · 2012 · Biochemical Engineering Journal
  37. Localization of mRNAs for trkB isoforms and p75 in rat retinal ganglion cells
    David Akira SUZUKI, Shintaro Nomura, Eiichi Morii, Yutaka Fukuda, Jun Kosaka · 1998 · Journal of Neuroscience Research
  38. Alzheimer amyloid-beta peptide forms denaturant-resistant complex with type epsilon 3 but not type epsilon 4 isoform of native apolipoprotein E.
    Zhongmin Zhou, Jonathan D. Smith, Paul Greengard, Sam Gandy · 1996 · PubMed Central
  39. Increased levels of α-1-antichymotrypsin in brains of patients with Alzheimer's disease correlate with activated astrocytes and are affected by APOE 4 genotype
    Licastro, Federico, Mallory, Margareth, Hansen, Lawrence A, Masliah, Eliezer · 1998 · Journal of Neuroimmunology
  40. Clinical and Neuropathological Correlates of Apolipoprotein E Genotype in Dementia with Lewy Bodies
    Andrew Singleton, Anna Wharton, Kirsty K O’Brien, Matthew P. Walker, Ian Grant McKeith, Clive G. Ballard, John Tiernan O'Brien, Robert Henry Perry, Paul G. Ince, James Alexander Edwardson et al. · 2002 · Dementia and Geriatric Cognitive Disorders
  41. Isolation and Characterization of Apolipoproteins from Murine Microglia
    Qiang Xu, Yonghong Li, Connie Cyras, David A. Sanan, Barbara Cordell · 2000 · Journal of Biological Chemistry
  42. Astrogliosis and the ApoE Genotype
    Margit Overmyer, Seppo Helisalmi, Hilkka S. Soininen, Markku Laakso, Paavo Riekkinen, Irina I. Alafuzoff · 1999 · Dementia and Geriatric Cognitive Disorders
  43. Association of Apolipoprotein E Polymorphism With Outcome After Aneurysmal Subarachnoid Hemorrhage
    Tero Niskakangas, Juha E Öhman, Mika Risto Niemela, Erkki Ilveskoski, Tarja A. Kunnas, Pekka J. Karhunen · 2001 · Stroke
  44. Probing the native strain in α1-antitrypsin
    Kee Nyung Lee, Sang Dai Park, Myeong‐Hee Yu · 1996 · Nature Structural & Molecular Biology
  45. Apolipoprotein E allele distribution in parents of Down's syndrome children
    Dimitrios Avramopoulos, Maria Grigoriadou, Michael Bjorn Petersen, Margareta Mikkelsen, M.B. Petersen, Dimitrios Vassilopoulos · 1996 · The Lancet
  46. The generation and function of soluble apoE receptors in the CNS
    Rebeck, G William, LaDu, Mary Jo, Estus, Steven, Bu, Guojun, Weeber, Edwin J · 2006 · Molecular Neurodegeneration
  47. Amyloid β-interacting partners in Alzheimer's disease: From accomplices to possible therapeutic targets
    Han, Sun-Ho, Park, Jong-Chan, Mook-Jung, Inhee · 2016 · Progress in Neurobiology
  48. CSF beta-amyloid, cognition, and APOE genotype in Alzheimer’s disease
    S Samuels, Jeremy M. Silverman, Deborah B. Marin, Elaine R. Peskind, S.G. Younki, David A. Greenberg, Elke Schnur, J. Santoro, Kenneth L. Davis · 1999 · Neurology
  49. Amyloid and Alzheimer's Disease: Inside and Out
    Joshua H. K. Tam, Stephen Pasternak · 2012 · Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques
  50. Assessment of Advanced Glycation End Products and Receptors and the Risk of Dementia
    Jinluan Chen, Sanne S. Mooldijk, Silvan Licher, Komal Waqas, M. Kamran Ikram, André Gerardus Uitterlinden, MCarola Zillikens, M. Arfan Ikram · 2021 · JAMA Network Open
  51. Apolipoprotein E and the Response of the Brain to Injury
    David Ian Graham, Karen J. Horsburgh, James A. R. Nicoll, Graham M. Teasdale · 1999 · Acta neurochirurgica. Supplementum
  52. Amyloid β 1-42 deposits do not lead to Alzheimer's neuritic plaques in aged dogs
    Thomas Wısnıewskı, Maciej M. Lalowski, Marketta Bobik, Michael RUSSELL, Joanna Benigna Strosznajder, Blas Frangione · 1996 · Biochemical Journal
  53. The Interaction of Amyloid-β with ApoE
    Donald B. Carter · 2005 · Sub-cellular biochemistry/Subcellular biochemistry
  54. Ca2+-dependent Binding of Human Serum Amyloid P Component to Alzheimer's β-Amyloid Peptide
    Hideaki Hamazaki · 1995 · Journal of Biological Chemistry
  55. Differences between the Pathogenesis of Senile Plaques and Congophilic Angiopathy in Alzheimer Disease
    Marcel M. Verbeek, Piet Eikelenboom, Robert M.W. de Waal · 1997 · Journal of Neuropathology & Experimental Neurology
  56. Alzheimer's Peptide Aβ1–42 Binds to Two β-Sheets of α1-Antichymotrypsin and Transforms It from Inhibitor to Substrate
    Sabina M Janciauskiene, Harvey N. Rubin, Christine Lukacs, H.T. Wright · 1998 · Journal of Biological Chemistry
  57. Alterations in Cerebrospinal Fluid Apolipoprotein E and Amyloid β -Protein after Traumatic Brain Injury
    Andrew D. Kay, Axel Petzold, Mary Kerr, Geoff Keir, E J Thompson, James A. R. Nicoll · 2003 · Journal of Neurotrauma
  58. Promotion of formation of amyloid fibrils by aluminium adenosine triphosphate (AlATP)
    Christopher Exley, Olga V. Korchazhkina · 2001 · Journal of Inorganic Biochemistry
  59. Evidence of oxidative stress and mitochondrial dysfunction in spinocerebellar ataxia type 2 (SCA2) patient fibroblasts: Effect of coenzyme Q10 supplementation on these parameters
    Nanna Cornelius, Jonathan Henry Wardman, Iain Parry Hargreaves, Viruna Neergheen, Anne Sigaard Bie, Zeynep Tümer, Jørgen Erik Nielsen, Troels T. Nielsen · 2017 · Mitochondrion
  60. Acetylcholinesterase, a senile plaque component, affects the fibrillogenesis of amyloid-β-peptides
    Alejandra R. Alvarez, Francisca C. Bronfman, Cristián A. Pérez, Matías Vicente, Jorge Garrido, Nibaldo C. Inestrosa · 1995 · Neuroscience Letters
  61. Metastability in the Inhibitory Mechanism of Human α1-Antitrypsin
    Hana Im, Eun Joo Seo, Myeong‐Hee Yu · 1999 · Journal of Biological Chemistry
  62. Protection against developmental retardation in apolipoprotein E-deficient mice by a fatty neuropeptide: Implications for early treatment of Alzheimer's disease
    Illana Gozes, Michal Bachar, Amos Bardea, Ariane Davidson, Sarah Rubinraut, Mati Fridkin, Eliezer Giladi · 1997 · Journal of Neurobiology
  63. Enhanced binding of advanced glycation endproducts (AGE) by the ApoE4 isoform links the mechanism of plaque deposition in Alzheimer's disease
    Yong Ming Li, Dennis W. Dickson · 1997 · Neuroscience Letters
  64. Apolipoprotein E Attenuates β‐Amyloid‐Induced Astrocyte Activation
    Jingru Hu, Mary Jo LaDu, Linda J. Van Eldik · 1998 · Journal of Neurochemistry
  65. ApoE4 reduction: An emerging and promising therapeutic strategy for Alzheimer's disease
    Li, Yonghe, Macyczko, Jesse R., Liu, Chia-Chen, Bu, Guojun · 2022 · Neurobiology of Aging
  66. The Neurobiology and Pharmacotherapy of Alzheimer's Disease
    Olivier Félician, Thomas A. Sandson · 1999 · Journal of Neuropsychiatry
  67. Interaction of Transthyretin with Amyloid β‐Protein: Binding and Inhibition of Amyloid Formation
    A. L. Schwarzman, Dmitry Goldgaber · 2007 · Novartis Foundation symposium
  68. Effects of APOE4 allelic dosage on lipidomic signatures in the entorhinal cortex of aged mice
    Miranda, André Miguel, Ashok, Archana, Chan, Robin Barry, Zhou, Bowen, Xu, Yimeng, McIntire, Laura Beth, Area-Gomez, Estela, Di Paolo, Gilbert, Duff, Karen E., Oliveira, Tiago Gil et al. · 2022 · Translational Psychiatry
  69. Alpha-1-antichymotrypsin (ACT or SERPINA3) polymorphism may affect age-at-onset and disease duration of Alzheimer's disease
    M. Ilyas Kamboh, Ryan L. Minster, Margaret Kenney, Ayla Öztürk, Purnima P. Desai, Candace M. Kammerer, Steven Trent DeKosky · 2005 · Neurobiology of Aging
  70. Greater medial temporal hypometabolism and lower cortical amyloid burden in ApoE4-positive AD patients
    Manja Lehmann, P. Ghosh, Catherine A. Madison, Anna Karydas, Giovanni Coppola, James P. O’Neil, Yadong Huang, Bruce L. Miller, William Jagust, Gil Dan Rabinovici · 2013 · Journal of Neurology Neurosurgery & Psychiatry
  71. Two-hybrid system as a model to study the interaction of beta-amyloid peptide monomers.
    Stephen R. Hughes, S Goyal, Jian Sun, Patricia A. Gonzalez‐DeWhitt, M A Fortes, Norbert G. Riedel, Sudhir R. Sahasrabudhe · 1996 · Proceedings of the National Academy of Sciences
  72. Mechanism of Interleukin-1- and Tumor Necrosis Factor α-Dependent Regulation of the α1-Antichymotrypsin Gene in Human Astrocytes
    Tomasz Kordula, Marcin Bugno, Russell E. Rydel, James W. Travis · 2000 · Journal of Neuroscience
  73. Two conformational states of amyloid β-peptide: implications for the pathogenesis of Alzheimer's disease
    Claudio A. Soto, Blas Frangione · 1995 · Neuroscience Letters
  74. Use of Genetic Variation as Biomarkers for Mild Cognitive Impairment and Progression of Mild Cognitive Impairment to Dementia
    Christiane Reitz, Richard P Mayeux · 2010 · Journal of Alzheimer s Disease
  75. Adult Neurogenesis, Neural Stem Cells and Alzheimers Disease: Developments, Limitations, Problems and Promises
    Philippe Taupin · 2009 · Current Alzheimer Research
  76. Type 2 diabetes mellitus in the pathophysiology of Alzheimer's disease
    Aparecida Marcelino de Nazareth · 2017 · Dementia & Neuropsychologia
  77. Vascular risk and genetics of sporadic late-onset Alzheimer’s disease
    Francesco Panza, Alessia D’Introno, Anna Maria Colacicco, Anna Maria Basile, Cristiano A. Capurso, Patrick G. Kehoe, Cristiano A. Capurso, Vincenzo Solfrizzi · 2003 · Journal of Neural Transmission
  78. Apolipoprotein E ε4 Allele Differently Affects the Patterns of Neuropsychological Presentation in Early- and Late-Onset Alzheimer’s Disease Patients
    Camillo Marra, Alessandra Bizzarro, Antonio Daniele, Lara De Luca, Monica Ferraccioli, Alessandro Valenza, Christina Brahe, Francesco Danilo Tiziano, Guido Gainotti, Carlo Masullo · 2004 · Dementia and Geriatric Cognitive Disorders
  79. Apolipoprotein E Carboxyl-terminal Fragments Are Complexed to Amyloids A and L
    Eduardo Miguel Castaño, Frances C. Prelli, Mordechai Pras, Blas Frangione · 1995 · Journal of Biological Chemistry
  80. Kinetic analysis of β-amyloid peptide aggregation induced by metal ions based on surface plasmon resonance biosensing
    Wen-Pin Hu, Guan‐Liang Chang, Shean-Jen Chen, Yu‐Min Kuo · 2006 · Journal of Neuroscience Methods
  81. Immunohistochemical study of distribution of apolipoproteins E and D in human cerebral β amyloid deposits
    Ana Navarro, Eva del Valle, Aurora Astudillo, Carmen González del Rey, Jorge Tolivia · 2003 · Experimental Neurology
  82. Pharmacogenomics of neurodegenerative diseases
    Davide Maimone, Roberto Dominici, Luigi M. E. Grimaldi · 2001 · European Journal of Pharmacology
  83. Apolipoproteins E3 and E4 induce, and transthyretin prevents accumulation of the Alzheimer's β-amyloid peptide in cultured vascular smooth muscle cells
    Bozena Mazur‐Kolecka, Janusz Frackowiak, Henryk M. Wı́sniewski · 1995 · Brain Research
  84. Tissue transglutaminase: A novel pharmacological target in preventing toxic protein aggregation in neurodegenerative diseases
    Micha M.M. Wilhelmus, Anne‐Marie van Dam, Benjamin Drukarch · 2008 · European Journal of Pharmacology
  85. Apolipoprotein E level and cholesterol are associated with reduced synaptic amyloid beta in Alzheimer’s disease and apoE TR mouse cortex
    Stephen P. Arold, Patrick M. Sullivan, Tina V. Bilousova, Edmond Teng, Carol A. Miller, Wayne W. Poon, Harry V. Vinters, Lindsey B. Cornwell, Tommy Saing, Gregory M. Cole et al. · 2011 · Acta Neuropathologica
  86. Apolipoprotein E protects cultured pericytes and astrocytes from D-Aβ1–40-mediated cell death
    Ilona B. Bruinsma, Micha M.M. Wilhelmus, Matthijs Kox, Robert Veerhuis, Robert M.W. de Waal, Marcel M. Verbeek · 2009 · Brain Research
  87. Targeting Apolipoprotein E/Amyloid β Binding by Peptoid CPO_Aβ17-21 P Ameliorates Alzheimer’s Disease Related Pathology and Cognitive Decline
    Shan Liu, Shin-Ae Park, Grant Allington, Frances C. Prelli, Yanjie Sun, Mitchell Martá-Ariza, Henrieta Scholtzova, Goutam K. Biswas, Bernard Brown, Philip B. Verghese et al. · 2017 · Scientific Reports
  88. Temporal Alterations in Cerebrospinal Fluid Amyloid β-Protein and Apolipoprotein E After Subarachnoid Hemorrhage
    Andrew Kay, Axel Petzold, Mary Kerr, Geoff Keir, E J Thompson, James A. R. Nicoll · 2003 · Stroke
  89. Genetics of Early-Onset Alzheimer Dementia
    Rosa Rademakers, Marc Cruts, Christine Van Broeckhoven · 2003 · The Scientific World JOURNAL
  90. A subset of senile dementia with high incidence of the apolipoprotein E ϵ2 allele
    Ikeda, Kenji, Akiyama, Haruhiko, Arai, Tetsuaki, Sahara, Naruhiko, Mori, Hiroshi, Usami, Mihoko, Sakata, Masuhiro, Mizutani, Toshio, Wakabayashi, Koichi, Takahashi, Hitoshi · 1997 · Annals of Neurology
  91. Identification and expression analysis of a potential familial Alzheimer disease gene on chromosome 1 related to AD3.
    Jian Li, Jiao Ma, Huntington Potter · 1995 · Proceedings of the National Academy of Sciences
  92. APOE4 is Associated with Differential Regional Vulnerability to Bioenergetic Deficits in Aged APOE Mice
    Area-Gomez, Estela, Larrea, Delfina, Pera, Marta, Agrawal, Rishi R., Guilfoyle, David N., Pirhaji, Leila, Shannon, Kathleen, Arain, Hirra A., Ashok, Archana, Chen, Qiuying et al. · 2020 · Scientific Reports
  93. Amyloid‐β‐induced Degeneration of Human Brain Pericytes Is Dependent on the Apolipoprotein E Genotype
    Marcel M. Verbeek, William E. Van Nostrand, Irene Otte‐Höller, Pieter Wesseling, Robert M.W. de Waal · 2000 · Annals of the New York Academy of Sciences
  94. GALLSTONE FORMATION
    Cynthia W. Ko, Sum P. Lee · 1999 · Gastroenterology Clinics of North America
  95. ApoAI deficiency results in marked reductions in plasma cholesterol but no alterations in amyloid-β pathology in a mouse model of Alzheimer's disease-like cerebral amyloidosis
    Fagan, Anne M., Christopher, Erin, Taylor, Jennie W., Parsadanian, Maia, Spinner, Michael, Watson, Melanie, Fryer, John D., Wahrle, Suzanne, Bales, Kelly R., Paul, Steven M. et al. · 2004 · The American Journal of Pathology
  96. Varicella Zoster Virus Infection of Primary Human Spinal Astrocytes Produces Intracellular Amylin, Amyloid-beta, and an Amyloidogenic Extracellular Environment.
    Andrew N. Bubak, Christina N. Como, Christina M. Coughlan, Noah R. Johnson, James E. Hassell, Teresa Mescher, Christy S. Niemeyer, R. Mahalingam, R. Cohrs, Timothy D. Boyd et al. · 2019 · Journal of Infectious Diseases
  97. Different mechanisms of apolipoprotein E isoform‐dependent modulation of prostaglandin E <sub>2</sub> production and triggering receptor expressed on myeloid cells 2 ( <i>TREM2</i> ) expression after innate immune activation of microglia
    Li, Xianwu, Montine, Kathleen S., Keene, C. Dirk, Montine, Thomas J. · 2015 · The FASEB Journal
  98. Apolipoprotein E Genotype Regulates Amyloid-β Cytotoxicity
    Micha M.M. Wilhelmus, Irene Otte‐Höller, Judianne Davis, William E. Van Nostrand, Robert M.W. de Waal, Marcel M. Verbeek · 2005 · Journal of Neuroscience
  99. Immunological and Anti-Chaperone Therapeutic Approaches for Alzheimer Disease
    Thomas Wısnıewskı, Blas Frangione · 2006 · Brain Pathology
  100. The apolipoprotein E allele epsilon 4 does not correlate with the number of senile plaques or neurofibrillary tangles in patients with Alzheimer's disease.
    Mikael Landén, Annika Thorsell, A. Wallin, Kaj Blennow · 1996 · Journal of Neurology Neurosurgery & Psychiatry